Medtronic plc (MDT)
Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated?
MDT's stronger growth and earnings outlook improve its case, but margin, currency and execution risks keep investors selective.
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
MDT Q1 Earnings Call Focuses on Broad Growth, Raised Guidance
Medtronic raises its fiscal 2027 outlook as growth broadens across major franchises and newer platforms, with robotics and ablation investments advancing.
Why Medtronic (MDT) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Medtronic's Stars Are Aligning for a Price Recovery
Medtronic NYSE: MDT is a good buy in late 2026 because stars such as value, growth, guidance, partnerships, and dividends are aligning. They point to sustained outperformance and potential acceleration but, more importantly, to robust capital returns.
Medtronic Q1 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
MDT beats Q1 earnings and revenue estimates as broad-based growth drives shares higher and prompts a fiscal 2027 guidance boost.
Here's What Key Metrics Tell Us About Medtronic (MDT) Q1 Earnings
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medtronic Q1 Earnings Call Highlights
Medtronic NYSE: MDT reported fiscal 2027 first-quarter revenue of $9.8 billion and adjusted earnings per share of $1.45, as the medical-device maker cited broad-based demand, commercial execution and momentum in several growth platforms.
Medtronic (MDT) Q1 Earnings and Revenues Top Estimates
Medtronic (MDT) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.26 per share a year ago.
Medtronic Lifts Outlook, Invests Over $700 Million in Heart Tech & Robotics
Medtronic raised its outlook for the year after posting higher fiscal first-quarter profit and sales, driven by broad-based demand and contributions from newer growth platforms.
Medtronic Stock Rises on Better-Than-Expected Earnings and $700 Million Investment in a Robot Surgeon
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million investment.
Medtronic, Dell and 3 Stocks to Watch Heading Into Tuesday
With U.S. stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
